- Home
- KYMR vs VICR Comparison
KYMR vs VICR Comparison
Compare KYMR & VICR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- VICR
- Stock Information
- Founded
- KYMR 2015
- VICR 1981
- Country
- KYMR United States
- VICR United States
- Employees
- KYMR N/A
- VICR N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- VICR Industrial Machinery/Components
- Sector
- KYMR Health Care
- VICR Technology
- Exchange
- KYMR Nasdaq
- VICR Nasdaq
- Market Cap
- KYMR 2.6B
- VICR 2.6B
- IPO Year
- KYMR 2020
- VICR N/A
- Fundamental
- Price
- KYMR $40.61
- VICR $51.54
- Analyst Decision
- KYMR Buy
- VICR Hold
- Analyst Count
- KYMR 15
- VICR 2
- Target Price
- KYMR $55.60
- VICR $43.00
- AVG Volume (30 Days)
- KYMR 532.1K
- VICR 186.5K
- Earning Date
- KYMR 02-20-2025
- VICR 02-20-2025
- Dividend Yield
- KYMR N/A
- VICR N/A
- EPS Growth
- KYMR N/A
- VICR N/A
- EPS
- KYMR N/A
- VICR 0.10
- Revenue
- KYMR $87,563,000.00
- VICR $355,544,000.00
- Revenue This Year
- KYMR N/A
- VICR N/A
- Revenue Next Year
- KYMR $33.16
- VICR $10.70
- P/E Ratio
- KYMR N/A
- VICR $511.14
- Revenue Growth
- KYMR 86.92
- VICR N/A
- 52 Week Low
- KYMR $26.92
- VICR $30.90
- 52 Week High
- KYMR $53.27
- VICR $61.05
- Technical
- Relative Strength Index (RSI)
- KYMR 47.90
- VICR 53.62
- Support Level
- KYMR $40.20
- VICR $46.17
- Resistance Level
- KYMR $44.34
- VICR $49.84
- Average True Range (ATR)
- KYMR 2.58
- VICR 1.90
- MACD
- KYMR 0.29
- VICR 0.11
- Stochastic Oscillator
- KYMR 57.47
- VICR 82.11
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.
About VICR Vicor Corporation
Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, advanced power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others. Geographically, it derives a maximum of its revenue from the Asia Pacific.